You just read:

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate, an Investigational Treatment for Actinic Keratosis, Presented at World Congress of Dermatology

News provided by

LEO Pharma

06 Jun, 2011, 13:54 BST